SSTR5 and ACTH-producing pituitary gland adenoma: Similarly, Hofland et al. reported that Pasireotide, through its SSTR5-mediated mechanism, significantly inhibited ACTH secretion in primary cultures of human corticotroph adenomas, reinforcing the therapeutic relevance of SSTR5 targeting in CD [71].